FDA clamping down on abuse of an OTC decongestant
Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says.
Mar 26, 2021
0
6
Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says.
Mar 26, 2021
0
6
Since the COVID-19 pandemic struck last March, psychiatric emergency visits at Rady Children's Hospital near San Diego have crept up as youths and teens struggle with virtual learning, social isolation and unstable home lives.
Feb 2, 2021
0
4
Wandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen in the early stages of dementia—even if the person has never wandered in the past.
Dec 3, 2020
0
9
I'm a clinical trials geek. I keep hearing people talk about the seven to ten years it takes to make a vaccine and how dangerous speeding this up might be. The word that keeps popping up is "rushed", and it is making the ...
Nov 25, 2020
0
1
In mid-September, China suspended importing fishery products from Indonesia due to novel coronavirus contamination in the outer packages.
Nov 20, 2020
1
2
One of the hottest topics around COVID-19 is the need for a vaccine for this new disease, which has had a huge impact on both human health and economies. The disease caught most people completely by surprise and shows no ...
Sep 11, 2020
0
3
Yesterday, the Victorian government released much-anticipated figures showing the proportion of the state's health-care workers who caught COVID-19 at work.
Aug 26, 2020
0
1
The novel coronavirus is not expected to disappear anytime soon. With physical distancing, virus testing, contact tracing, and potentially new therapeutics, we may be able to keep it partially at bay. But many eyes are looking ...
Jul 14, 2020
0
8
Experts weigh in on recent online reports that warn of frightening health consequences from new fifth generation (5G) wireless networks. Within current exposure limits, there appears to be little or no risk of adverse health ...
Jun 24, 2020
0
12
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
Jun 20, 2020
0
28